Anatomy and Function of the Basal Ganglia Flashcards

L9 and L10

1
Q

Give an overview of Basal Ganglia anatomy

A
  • Lentiform nucleus
    • Putamen
    • Globus pallidus
  • Corpus striatum
    • Caudate nucleus
    • Putamen
    • Pallidum
      • globus pallidus internal + external
  • Neostriatum = dorsal striatum
    • Caudate
    • Putamen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain how the basal ganglia interfaces with the cortex

A
  • the striatum and pallidum form the basal ganglia which transmits information to the thalamus
  • the thalamus interfaces with the cerebral cortex which feedback to the Basal Ganglia
  • There are 4 basal ganglia loops, two motor, and two-non-motor
    • Motor
    • Oculomotor
    • Prefrontal
    • Limbic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain the Loops in the basal ganglia

A
  • each have a Cortical Input –>
    • motor, premotor somatosensory cortex
    • posterior parietal, prefrontal cortex
    • Dorsolateral prefrontal cortex
    • Amygdala, hippocampus, orbitofrontal, anterior cingulate, temporal cortex
  • striatum –>
    • putamen
    • body of the caudate
    • anterior caudate
    • ventral striatum
  • pallidum –>
    • lateral, globus pallidus, internal segment
    • Globus pallidus, internal segment, substantia nigra pars reticulata (x2)
    • ventral pallidum
  • thalamus –>
    • ventral lateral and lateral anterior nuclei
    • mediodorsal and ventral anterior nuclei (x2)
    • Mediodorsal nucleus
  • then back to the cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the Direct pathway

A
  • promotes movement
  • provides a disnihibtory effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the indirect/ hyper-direct pathway

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give an overview of how the basal ganglia pathways work

A
  • Inhibitory signals are the release of GABA
  • Excitatory signals are the release of Glutamate
  • Cortex –> striatum is excitatory
  • Striatum outputs –> inhibitory
  • Thalamus –> cortex is excitatory
  • The inhibition of thalamus prevents movement
  • Reducing inhibition of thalamus facilitates movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is the input from the cortex modulated by the Striatum?

A
  • Controlled by DA and ACh
  • 2 populations of specialised dopamine receptors D1 and D2 medium spiny neurons
    • D1: use G-proteins that increase cAMP - enhance the excitatory input from the cortex
    • D2: use G-proteins that decrease cAMP - suppress the excitatory input from the cortex
  • There are Striatum interneurons that use ACh
    • this opposes the action of DA, tipping the pathway towards prevention of movement
  • the release of Dopamine tips pathway towards the promotion of movement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the basal ganglia syndrome Hemiballismus

A
  • it is a hyperkinertic movement disorder that causes ballistic involuntary movements of the limbs
  • caused by damage to the subthalamic nucleus
    • ​stroke in the STN is the most common cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give a description of Tic disorders

A
  • Brief repetitive stereotypes movements with a premonitory urge.
    • Simple: like blinking, coughing
    • Complex: jumping or twirling
    • Plus: motor disorder
    • Coprolalia: swearing - rare
  • Reduced by distraction and concentration
  • Worse with anxiety or fatigue.
    • 50% have ADHD
    • 33.3% have OCD
    • Up to 50% have anxiety
  • Tourette syndrome is the more severe expression of a spectrum of tic disorders,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is this an MRI of?

A

Subthalamic Nucleus Stroke

  • can cause Hemiballismus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the action Prefrontal (cognitive loop) in the basal ganglia and its presentation in Parkinson’s Disease (PD)

A
  • Pre-frontal cortex (dorso-lateral) → Caudate → Anterior Putamen → Globus Pallidus →Ventral anterior (VA) thalamic nucleus →Prefrontal cortex.
  • Role in forward planning of complex motor intentions (volition).
  • Therefore when a motor task becomes automatic, the motor loop of the basal ganglia takes over.
  • PD patients have impairment of working memory
    • Activation of the supplementary motor area on intended movements – Barietschaft potential which can be recorded Neurophysiologically and useful for assessing patients with a functional neurological disorder.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain the action of the Limbic loop in the basal ganglia and it’s presentation in Parkinsons Disease (PD)

A
  • Inferior prefrontal cortex → Nucleus Accumbens → Ventral Pallidum → Medio-dorsal nucleus of the thalamus → Inferior frontal cortex.
  • Role in the visible expression of emotion. E.g smiling, showing aggression.
  • This may explain why PD patiends have facial masking.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the action of the Oculomotor loop in the basal ganglia and its presentation in Parkinson’s Disease (PD)

A
  • Frontal eye field and parietal cortex → Caudate nucleus → Substantia Nigra (Pr) → VA nucleus of thalamus → Frontal eye field and parietal cortex
  • Ocular fixation is held by tonic activity (repetitive impulses) in the SN (Pr)
  • When a saccade (voluntary movement) is made, the superior colliculus is disinhibited by the activated oculomotor loop.
  • The superior colliculus neurons cause the eyes to make a rapid movement to a new target. The Sn(Pr) then resume tonic activity holding the visual gaze in that position.
  • In PD: loss of dopamine neurons in the SN (Pr) means there is less disinhibition of the superior colliculus neurons resulting in slow eye movement (ocular hypokinesia).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Chorea and when would choreiform movements present?

A
  • Jerky, brief, irregular contractions that are not repetitive or rhythmic, but appear to flow from one muscle to the next. patient appears fidgety, restless
  • Can present when
    • there is a pathology in the STN
    • Huntington’s disease
    • Neuroleptic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain what Huntington’s Disease is

A
  • autosomal dominant degenerative disease
    • CAG trinucleotide repeat on chromosome 4
    • the longer the repeat sequence the earlier the onset- seems to ‘anticipate’ with each generation
  • Cognitive presentation
    • inability to make a decision and multitask, slowness of thought
  • Behavioural presentaion
    • irritability, depression, apathy, anxiety, delusions
  • Physical presentation
    • Chorea, motor persistence, dystonia, eye movements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Dystonia?

A
  • Unintentional sustained muscle contractions leading to abnormal postures, can be painful

Pathophysiology

  • Functional PET studies suggest abnormal activity in the motor cortex, supplementary motor areas, cerebellum and basal ganglia
  • Abnormal DA activity in basal ganglia: some caused by blocking DA receptors, some dystonia being Levodopa responsive

Causes

  • Stroke, Brain Injury
  • Encephalitis
  • PD
  • Huntingtons disease
17
Q

What is Myoclonus?

A
  • Myoclonus is a sudden muscle spasm. The movement is involuntary and can’t be stopped or controlled
  • possibly an imbalance between excitatory and inhibitory neurotransmitters
    • hence can be treated with antiepileptic drugs
  • maybe a perturbation of the motor control system –> disequilibrium
  • Caused by
    • Juvenile Myoclonic Epilepsy
    • Brain Hypoxia
    • Prion disease
18
Q

What is Tremor?

Essential tremor treatment?

A
  • Involuntary, rhythmic, sinusoidal alternating movements of part of the body, and affects different parts of the body
  • Occurs at different times: Rest, Postural, Kinetic (Essential Tremor (ET) is most common)

Pathophysiology

  • Postulated theory: Increased activity in the cerebellothalamocortical circuit.
  • PD: Dopamine dysfunction in the pallidum results in this.
  • ET: GABAergic dysfunction in the cerebellum causes this.
    • Ultrasound therapy?
19
Q

What drug treatment is there for hyperkinetic movement disorders?

A

Tics/Chorea/Ballismus

  • Dopamine receptor blocking agents
    • eg haloperidol, chlorpromazine, pimozide, risperidone
  • Dopamine depleting agents
    • eg Tetrabenazine, Reserpine
  • Atypical anti-psychotics
    • eg Clozapine, Olanzapine, Aripiprazole
20
Q

What is the response of the basal ganglia to DA blocking agents

A
  • acute problems
    • Oculogyric crisis
    • Neuroleptic malignant syndrome
  • subacute problems
    • drug-induced Parkinsonism
  • long term dyskinesia
21
Q

What is an Oculgyric crisis?

A
  • acute response to DA blocking drugs causing
  • Fixed stare, upward deviation of eyes
  • Neck extension, Trunk extension
  • Jaw spasms +/- tongue protrusion
  • ‘Acute dystonic’ reaction
22
Q

What is Neuroleptic Malignant Syndrome?

A
  • Acute medical emergency developing over hours/ days in response to Dopamine blocking drugs
  • Rigidity/ muscle breakdown – raised CPK.
  • Fever
  • Autonomic instability (volatile BP/PR)
  • Confusion

    • Serotonin syndrome can be distinguished from NMS., SS occurs within 24 hours. NMS (days to weeks), SS: Hyperreactivity, NMS: hyporeflexia, severe muscular rigidity
23
Q

What is Tardive Dyskinesia?

A
  • Choreic oral-facial movements (video), dystonic trunk posturing
    • clinical manifestations including chorea, athetosis, dystonia, akathisia, stereotyped behaviours, rarely tremor.
    • older patients:
      • Protruding and twisting movements of the tongue
      • Pouting, puckering, or smacking movements of the lips
      • Retraction of the corners of the mouth
      • Bulging of the cheeks
      • Chewing movements
      • Blepharospasm
  • likely due to dopamine supersensitivity of basal ganglia
    • i.e. secondary receptor/ plastic changes
  • Treatment:
    • gradual withdrawal of offending agent, substitution with an atypical anti-psychotic;
    • use of a dopamine depleting agent (tetrabenazine);
    • use of a benzodiazepine (clonazepam) if distressing
24
Q

Explain the symptoms and physical signs of Parkinson’s Disease is?

motor and non-motor

A
  • symptoms are:
    • Slowness of movement (also thought/ psychomotor retardation)
    • Stiffness
    • Shaking.
  • physical signs include:
    • Slowness and poverty of movement (bradykinesia) e.g. loss of facial expression and arm swing, difficulty with fine movements
    • Voluntary movements harder to initiate (akinesia)
  • non-motor symptoms
    • Mood: Depression, anxiety
    • Dementia: slowed thought, mental inflexibility,
    • Autonomic involvement: Postural hypotension, Hypersalivation
    • Sleep disturbance: Restless legs, REM parasomnia
    • Reduced sense of smell
25
Q

What is the pathophysiology of Parkinson’s Disease?

A
  • Decreased dopamine input leads to reduced activation of direct pathway and reduced inhibition of the indirect pathway
  • leads to reduced movements
26
Q

What is Parkinson’s disease and some of it’s causes?

A
  • A neurodegenerative condition, primarily affecting dopaminergic cells of the substantia nigra
  • Lewy bodies are seen in histopathological exams

Neurodegenerative

  • (Idiopathic) Parkinson’s disease >80%
  • Diffuse Lewy body disease
  • Atypical Parkinsonism (MSA, PSP, CBD)
    • Multiple system atrophy, Progressive supranuclear palsy, Corticobasal degeneration

Secondary

  • Drugs (eg haloperidol, MPTP)
  • Cerebrovascular disease
  • Hydrocephalus
  • Toxicity/ metal deposition disorders

Genetic

  • Metabolic - Wilson’s disease (copper deposition)
  • Rare familial (dominant/ recessive) causes
27
Q

What are some PD early drug therapies?

A
  • Amantadine
    • Initially anti-flu agent
    • Glutamate agonist
  • AnticholinergicsProcyclidine, Benzhexol
    • May help with tremor
    • Limited by side effects (confusion, urinary retention, dry mouth…)
  • Monoamine oxidase inhibitors
28
Q

Monoamine Oxidase Inhibitors (MAO-I)

A
  • Prevent breakdown of monoamine chemical neurotransmitters; 2 isoforms:
    • MAO- type A: serotonin, adrenaline, noradrenaline, dopamine
    • MAO- type B: dopamine
  • Non-selective MAO-I: for depression (Moclobemide);
    • rarely used now due to problems with metabolising dietary amines/ tryptophans – the risk of hypertensive crisis – cheese, red wine, marmite
  • More selective MAO- IB: for Parkinson’s disease (Selegiline, Rasagiline) – no dietary restrictions
29
Q

Go over the use of L-Dopa in treating Dyskinesias

A
  • always combined with Dopa decarboxylase inhibitor to prevent peripheral conversion to dopamine
  • gets progressively less effective as the disease progresses
30
Q

what is Entacapone/Tolcapone

A
  • reduces peripheral metabolism of L-dopa,
  • increases duration of action of L-dopa, increases efficacy
  • makes dyskinesia worse, diarrhoea and tolcapone causes liver disease
31
Q

What is Duodopa?

A
  • it’s a duodenal L-dopa infusion for advanced PD
  • absorption affected by poor gastric motility/constipation and diet/ poor protein load
  • Unpredictable bioavailability makes it very difficult to hit narrow therapeutic window in advanced PD (for ON without dyskinesia)
  • Direct delivery of L-dopa to the duodenum via infusion pump potentially very useful strategy to manage motor fluctuations.
  • But very cumbersome/expensive (20K/year)
  • Does not affect disease progression
32
Q

What Dopamine agonists are used in treating PD?

  • what are the pros and cons
A

Example

  • Pramipexole, Ropinirole (non-ergot)
  • Rotigotine
  • Apomorphine
    • Bypass degenerating nigrostriatal neurons
    • Directly activate dopamine receptors.
    • No need for enzymatic conversion.
    • More stable and longer-acting.
    • can cause Dopamine dysregulation syndrome
33
Q

What is Apomorphine?

A
  • It’s a dopamine agonist given by s/c infusion
  • PROS: every effective with and instant effect, reduces dyskinesia by allowing continuous DA stimulation
  • CONS: only for the right patients, causes skin nodules
34
Q

What are some non-drug therapies for PD?

A
  • Deep brain stimulation
  • high-frequency stimulation causing inhibition of neurons by depolarising blocks
  • disrupts synchronous basal ganglia rhythms
  • Targets:
    • STN for PD
    • Pallidum for dystonia
    • Thalamus for tremor
  • diseases will still progress and no effect on non-motor
    • dementia, dysautonomia, postural instability
  • Future treatments include: neurorestorative treatment, and neuroprotective treatments